← back to search

Milana Frenkel‐Morgenstern

Reichman University · IL
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, RNA modifications and cancer, RNA and protein synthesis mechanisms, and Genomics and Phylogenetic Studies.
h-index
44
citations
19,229
works
148
NIH funding
primary concept
Biology
email

Recent publications

ChiTaRS 8.0: the comprehensive database of chimeric transcripts and RNA-seq data with applications in liquid biopsy.
2025cited by 2position: contributordoi
Applications for Circulating Cell-Free DNA in Oral Squamous Cell Carcinoma: A Non-Invasive Approach for Detecting Structural Variants, Fusions, and Oncoviruses.
2025cited by 1position: contributordoi
Non-Optimal Codon Usage Regulates Cell Cycle Progression: Functional Insights Of Codon Optimization of CDK1 and NUF2 Genes
2025cited by 0position: contributordoi
Functional and regulatory impact of chimeric RNAs in human normal and cancer cells.
2023cited by 8position: contributordoi
The landscape of differential splicing and transcript alternations in severe COVID-19 infection.
2023cited by 6position: contributordoi
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Nature Genetics 2023cited by 5position: middledoi
Author Correction: Patterns of somatic structural variation in human cancer genomes
Nature 2023cited by 4position: middledoi
Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
Nature Genetics 2023cited by 4position: middledoi
Publisher Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
2023cited by 3position: contributordoi
The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients.
2023cited by 2position: contributordoi
Author Correction: Genomic basis for RNA alterations in cancer
Nature 2023cited by 1position: middledoi
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
Nature Genetics 2023cited by 1position: middledoi
Applications for Circulating Cell-Free DNA in Oral Squamous Cell Carcinoma: A Non-Invasive Approach for Detecting Structural Variants, Fusions, and Oncoviruses
2023cited by 0position: contributordoi
Review of: "[Review] Early Real World Evidence on the Relative SARS-CoV-2 Vaccine Effectiveness of Bivalent COVID-19 Booster Doses: a Narrative Review"
2023cited by 0position: contributordoi
Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.
2022cited by 26position: contributordoi
tRNA methylation resolves codon usage bias at the limit of cell viability.
2022cited by 20position: contributordoi
Evolutionary impact of chimeric RNAs on generating phenotypic plasticity in human cells.
2022cited by 16position: contributordoi
Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis.
2022cited by 11position: contributordoi
Fusion proteins mediate alternation of protein interaction networks in cancers.
2022cited by 8position: contributordoi
Seasonal UV exposure and vitamin D: association with the dynamics of COVID-19 transmission in Europe.
2022cited by 7position: contributordoi
The Landscape of Novel Expressed Chimeric RNAs in Rheumatoid Arthritis.
2022cited by 4position: contributordoi
The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study.
2022cited by 4position: contributordoi
Incipient Sympatric Speciation and Evolution of Soil Bacteria Revealed by Metagenomic and Structured Non-Coding RNAs Analysis.
2022cited by 4position: contributordoi
tRNA Methylation Resolves Codon Usage Bias at the Limit of Cell Viability
2022cited by 1position: contributordoi
Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
Nature Communications 2022cited by 0position: middledoi
Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
Nature Communications 2022cited by 0position: middledoi
Improving patient survival by direct targeting of chimeric protein-protein interaction networks
2022cited by 0position: contributordoi
Mutated Tumor Suppressors Follow Oncogenes Profile by the Gene Hypermethylation of Partners in the Protein Interaction Networks
2022cited by 0position: contributordoi
Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis
Molecular Oncology 2021cited by 47position: lastdoi
Specific Susceptibility to COVID-19 in Adults with Down Syndrome
NeuroMolecular Medicine 2021cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 34 papers (2019–2025)Sumit Mukherjee · National Institutes of Health11 papers (2021–2023)Alessandro Gorohovski · Bar-Ilan University8 papers (2020–2022)Rajesh Detroja · University Health Network7 papers (2021–2025) · 4 papers (2019–2022)Mahua Bhattacharya · Bar-Ilan University4 papers (2022–2025)Sunanda Biswas Mukherjee · Bar-Ilan University3 papers (2022–2023) · 3 papers (2012–2021)Andrew A. Kanner · Tel Aviv University2 papers (2021–2022)Eugene Merzon · Tel Aviv Sourasky Medical Center2 papers (2020–2020)Ya-Ming Hou · University of Pennsylvania2 papers (2022–2022)Isao Masuda · Thomas Jefferson University2 papers (2022–2022)Ilan Green · Ben-Gurion University of the Negev2 papers (2020–2022) · 1 papers (2021–2021)Eugene Merzon · Ariel University1 papers (2021–2021)Sagi Harnof · Rabin Medical Center1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2012–2012)Rameen Beroukhim · Broad Institute1 papers (2023–2023)Charlotte Flueh · Max Delbrück Center1 papers (2021–2021)